{"id":2330,"date":"2015-05-05T14:10:13","date_gmt":"2015-05-05T18:10:13","guid":{"rendered":"https:\/\/www.acce.ca\/new\/?page_id=2330"},"modified":"2016-10-28T16:46:53","modified_gmt":"2016-10-28T20:46:53","slug":"%e9%84%ba%e5%9c%8b%e9%9b%84%e5%85%88%e7%94%9f","status":"publish","type":"page","link":"https:\/\/www.acce.ca\/new\/zh\/%e9%84%ba%e5%9c%8b%e9%9b%84%e5%85%88%e7%94%9f\/","title":{"rendered":"\u913a\u570b\u96c4\u5148\u751f"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.acce.ca\/new\/old_site\/about_acce\/alank2.jpg\" alt=\"Alan Kwong\" width=\"118\" border=\"1\"><br \/>\n<strong>\u9867\u554f<br \/>\n\u913a\u570b\u96c4\u5148\u751f<br \/>\n\u96fb\u5b50\u90f5\u7bb1\uff1a\u00a0<\/strong><a href=\"mailto:alan.k@pharmeng.com\"><strong>alan.k@pharmeng.com<\/strong><\/a><\/p>\n<p>\u913a\u570b\u96c4\u5148\u751f\u76ee\u524d\u662fPharmEng Technology \u7684\u9996\u5e2d\u57f7\u884c\u5b98\u548c\u7e3d\u7d93\u7406\u3002PharmEng\u662f\u4e00\u9593\u5411\u88fd\u85e5\u548c\u751f\u7269\u6280\u8853\u884c\u696d\u63d0\u4f9b\u570b\u969b\u8aee\u8a62\u548c\u57f9\u8a13\u6a5f\u69cb\u7684\u516c\u53f8\u3002PharmEng\u5728\u52a0\u62ff\u5927\u3001\u7f8e\u570b\u548c\u4e9e\u6d32\u64c1\u6709100\u540d\u54e1\u5de5\u3002\u913a\u570b\u96c4\u5148\u751f\u7684\u5408\u4f5c\u6a5f\u69cb\u5305\u62ecOntario Cancer Institute\u3001Connaught Laboratories Limited (\u76ee\u524d\u662f Sanofi Pasteur)\u3001Purdue Frederick Inc.\u3001NuPharm Inc.\uff08Apotex\u7684\u5b50\u516c\u53f8\uff09\u3001Glaxo Canada Inc.\u3001\u829d\u52a0\u54e5John Brown Engineering\u548c\u7d10\u7d04Taro Pharmaceuticals USA \u3002<\/p>\n<p>1997\u5e74\uff0c\u913a\u570b\u96c4\u5148\u751f\u5f9e\u7d10\u7d04\u56de\u5230\u591a\u502b\u591a\u5275\u8fa6PharmEng Technology\uff08<a href=\"http:\/\/www.pharmeng.com\/\">www.pharmeng.com<\/a>\uff09\u3002 2005\u5e74\uff0cPharmEng Technology\u7372\u5f97\u5275\u696d\u5354\u9032\u6703\u4e4b\u52a0\u62ff\u5927\u5091\u51fa\u83ef\u88d4\u5275\u696d\u5bb6\u9078\u8209\u300c\u6700\u4f73\u570b\u969b\u5546\u696d\u734e\u300d\u3002\u913a\u5148\u751f\u65bc\u5bc6\u6b47\u6839\u5927\u5b78\u7372\u5f97\u5316\u5b78\u5de5\u7a0b\u5b78\u58eb\u5b78\u4f4d\uff0c\u65bc\u591a\u502b\u591a\u5927\u5b78\u7372\u5f97\u5de5\u5546\u7ba1\u7406\u78a9\u58eb\u5b78\u4f4d\u3002\u4ed6\u4e5f\u662f\u5728\u5b89\u7701\u8a3b\u518a\u5c08\u696d\u5de5\u7a0b\u5e2b\u3002\u913a\u5148\u751f\u4e5f\u662f\u842c\u9326Stouffville\u91ab\u9662\u57fa\u91d1\u6703\u548c\u591a\u502b\u591a\u4e9e\u6d32\u4e8c\u6230\u53f2\u5be6\u7dad\u8b77\u6703\uff08\u591a\u502b\u591a\u53f2\u7dad\u6703\uff09\u7684\u8463\u4e8b\u6703\u6210\u54e1\u3002<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u9867\u554f \u913a\u570b\u96c4\u5148\u751f \u96fb\u5b50\u90f5\u7bb1\uff1a\u00a0alan.k@pharmeng.com \u913a\u570b\u96c4\u5148\u751f\u76ee\u524d\u662fPharmEng Technology \u7684\u9996\u5e2d\u57f7\u884c\u5b98\u548c\u7e3d\u7d93\u7406\u3002PharmEng\u662f\u4e00\u9593\u5411\u88fd\u85e5\u548c\u751f\u7269\u6280\u8853\u884c\u696d\u63d0\u4f9b\u570b\u969b\u8aee\u8a62\u548c\u57f9\u8a13\u6a5f\u69cb\u7684\u516c\u53f8\u3002PharmEng\u5728\u52a0\u62ff\u5927\u3001\u7f8e\u570b\u548c\u4e9e\u6d32\u64c1\u6709100\u540d\u54e1\u5de5\u3002\u913a\u570b\u96c4\u5148\u751f\u7684\u5408\u4f5c\u6a5f\u69cb\u5305\u62ecOntario Cancer Institute\u3001Connaught Laboratories Limited (\u76ee\u524d\u662f Sanofi Pasteur)\u3001Purdue Frederick Inc.\u3001NuPharm Inc.\uff08Apotex\u7684\u5b50\u516c\u53f8\uff09\u3001Glaxo Canada Inc.\u3001\u829d\u52a0\u54e5John Brown Engineering\u548c\u7d10\u7d04Taro Pharmaceuticals USA \u3002 1997\u5e74\uff0c\u913a\u570b\u96c4\u5148\u751f\u5f9e\u7d10\u7d04\u56de\u5230\u591a\u502b\u591a\u5275\u8fa6PharmEng Technology\uff08www.pharmeng.com\uff09\u3002 2005\u5e74\uff0cPharmEng Technology\u7372\u5f97\u5275\u696d\u5354\u9032\u6703\u4e4b\u52a0\u62ff\u5927\u5091\u51fa\u83ef\u88d4\u5275\u696d\u5bb6\u9078\u8209\u300c\u6700\u4f73\u570b\u969b\u5546\u696d\u734e\u300d\u3002\u913a\u5148\u751f\u65bc\u5bc6\u6b47\u6839\u5927\u5b78\u7372\u5f97\u5316\u5b78\u5de5\u7a0b\u5b78\u58eb\u5b78\u4f4d\uff0c\u65bc\u591a\u502b\u591a\u5927\u5b78\u7372\u5f97\u5de5\u5546\u7ba1\u7406\u78a9\u58eb\u5b78\u4f4d\u3002\u4ed6\u4e5f\u662f\u5728\u5b89\u7701\u8a3b\u518a\u5c08\u696d\u5de5\u7a0b\u5e2b\u3002\u913a\u5148\u751f\u4e5f\u662f\u842c\u9326Stouffville\u91ab\u9662\u57fa\u91d1\u6703\u548c\u591a\u502b\u591a\u4e9e\u6d32\u4e8c\u6230\u53f2\u5be6\u7dad\u8b77\u6703\uff08\u591a\u502b\u591a\u53f2\u7dad\u6703\uff09\u7684\u8463\u4e8b\u6703\u6210\u54e1\u3002 &nbsp;<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2330","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.acce.ca\/new\/wp-json\/wp\/v2\/pages\/2330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.acce.ca\/new\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.acce.ca\/new\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.acce.ca\/new\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.acce.ca\/new\/wp-json\/wp\/v2\/comments?post=2330"}],"version-history":[{"count":9,"href":"https:\/\/www.acce.ca\/new\/wp-json\/wp\/v2\/pages\/2330\/revisions"}],"predecessor-version":[{"id":4394,"href":"https:\/\/www.acce.ca\/new\/wp-json\/wp\/v2\/pages\/2330\/revisions\/4394"}],"wp:attachment":[{"href":"https:\/\/www.acce.ca\/new\/wp-json\/wp\/v2\/media?parent=2330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}